Proteomics

Dataset Information

0

A CTL-inspired Killing System Reveals Ultralow-dose Chemotherapy is Sufficient for Inducing a Pyroptosis-mediated Antitumour Immune Function


ABSTRACT: A Cytotoxic T lymphocyte-inspired system capable of using ultralow-dose chemical drugs to manipulate cell death is needed to investigate the antitumour immunotherapy. Recent studies revealed pyroptosis, a proinflammatory type of cell death, could promote antitumour immune function. However, high-dose chemotherapy led to cytokine release syndrome by pyroptosis. Therefore, pyroptosis- inducing ultralow-dose chemotherapy was potential in preclinical and clinical research, but its efficacy, safety and the antitumour immune responses were not clear. Here, we established a near-infrared light controllable killing system (BIK system) by which ultralow-dose doxorubicin could be spatiotemporally transported to immunosuppressive tumour cells and mediate efficient pyroptosis. Compared with using DOX directly, the BIK system reduced total drug consumption to less than one- thirtieth the common dose in vitro. MPI imaging and fluorescence imaging showed our BIK system exhibited good tumour targeting and tumour penetration. We applied this system for pyroptosis-induced antitumor therapies, and the results showed that less than 43 µg kg-1 DOX was sufficient for GSDME-positive tumour regression with negligible injuries to major organs. Notably, the gasdermin-deficient 4T1 tumours could be controlled by combining BIK system with decitabine treatment. The antitumour immune function were proven to correlate with the impressive efficacy of pyroptosis-inducing ultralow-dose chemotherapy, and the concomitant immune memory prevented metastasis, but high-dose DOX led to poor T cells infiltration which caused immunosuppression and lung metastasis. Owing to the robust antitumour immune function induced by BIK system, advanced-stage bulky tumours could be controlled or shrunken by synergizing with anti-PD-1 therapy. This study provided new insights into the design of nanoassisted systems for activating the antitumour immune function by microstimulation; our application of the BIK system suggested that ultralow-dose chemotherapy was sufficient for inducing a robust pyroptosis-mediated antitumour immune function

INSTRUMENT(S): 6410 Triple Quadrupole LC/MS

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Cell Culture, Macrophage

SUBMITTER: hao yin  

LAB HEAD: hao yin

PROVIDER: PXD047873 | Pride | 2024-02-23

REPOSITORIES: Pride

Similar Datasets

2023-09-05 | PXD044912 | Pride
2023-08-22 | GSE227675 | GEO
2023-05-22 | GSE215417 | GEO
2022-02-17 | PXD029795 | Pride
2023-03-11 | PXD025633 | Pride
2020-02-03 | MODEL2002030001 | BioModels
2022-07-29 | GSE209763 | GEO
2020-01-09 | MODEL1912120003 | BioModels
2022-03-24 | GSE199299 | GEO
2019-08-02 | BIOMD0000000776 | BioModels